The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages 1007-1012

  Laurenti, Luca ^a   Tarnani, Michela ^a   Nichele, Ilaria ^b   Ciolli, Stefania ^c   Cortelezzi, Agostino ^d   Forconi, Francesco ^e   Rossi, Davide ^f   Mauro, Francesca Romana ^g   D'Arena, Giovanni ^h   Del Poeta, Giovanni ⁱ   Montanaro, Marco ^j   Morabito, Fortunato ^k   Musolino, Caterina ^l   Callea, Vincenzo ^m   Falchi, Lorenzo ⁿ   Tedeschi, Alessandra ^o   Ambrosetti, Achille ^b   Gaidano, Gianluca ^f   Leone, Giuseppe ^a   Foà, Robin ^g  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h REFERRAL CANCER CENTER OF BASILICATA   (Italy)

ⁱ UNIVERSITY OF ROME TOR VERGATA   (Italy)

^j Sant'Anna Hospital Ronciglione   (Italy)

^k Unit of Geriatrics   (Italy)

^l UNIVERSITY OF MESSINA   (Italy)

^m BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

ⁿ UNIVERSITY OF PERUGIA   (Italy)

^o OSPEDALE NIGUARDA CA GRANDA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; ITALY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; MALE; MEDICAL RECORDS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; NEOPLASMS, SECOND PRIMARY; ONCOLOGY SERVICE, HOSPITAL; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 81355160457     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22171     Document Type: Article

References (66)

1. Berg JW. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J Natl Cancer Inst 1967; 38: 741-752.
2. Hyman GA. Increased incidence of neoplasia in association with chronic lymphocytic leukaemia. Scand J Haematol 1969; 6: 99-104.
3. Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Semin Oncol 1998; 25: 27-33. Review.
4. Gunz FW, Angus HB. Leukemia and cancer in the same patient. Cancer 1965; 18: 145-152.
5. Hansen MM. Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. Scand J Haematol 1973; 18: 105-114.
6. Zarrabi MH, Grünwald HW, Rosner F. Chronic lymphocytic leukemia terminating in acute leukemia. Arch Intern Med 1977; 137: 1059-1054.
7. Gargallo P, Cacchione R, Chena C, et al. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: Evidence of distinct lineage-associated genomic events. Cancer Genet Cytogenet 2005; 161: 74-77.
8. Chang H, Sutherland R, Nayar R, et al. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: Evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting. Cancer Genet Cytogenet 2004; 152: 146-148.
9. Bhagavathi S, Borromeo V, Desai H, et al. Case report and literature review: A rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia. Ann Clin Lab Sci 2008; 38: 405-409.
10. Salim R, Wang L, Lin K, et al. Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukaemia. Leuk Lymphoma 2002; 43: 2225-2227.
11. Esteve J, Cervantes F, Rives S, et al. Simultaneous occurrence of B-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis. Haematologica 1997; 82: 596-599.
12. Vilpo JA, Klemi P, Lasilla O, et al. Concomitant presentation of two chronic leukemias: Evidence for independent clonal evolution. Am J Hematol 1980; 8: 205-211.
13. Leoni F, Ferrini PR, Castoldi GL, et al. Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia. Haematologica 1987; 72: 253-256.
14. Browett PJ, Pattinson J, Pinkney J, et al. Gene probing analysis demonstrates independent clonal evolution of coexistent chronic myeloid and chronic lymphocytic leukemia. Eur J Haematol 1988; 40: 181-184.
15. Maher VE, Gill L, Townes PL, et al. Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Cancer 1993; 71: 1993-1997.
16. Crescenzi B, Sacchi S, Marasca R, et al. Distinct genomic events in myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B chronic lymphocytic leukemia. Leukemia 2002; 16: 955-956.
17. Mansat-De Mas V, Rigal-Huguet F, Cessar G, et al. Chronic myeloid leukemia associated with B-cell chronic lymphocytic leukemia: Evidence of two separate clones as shown by combined cell-sorting and fluorescence in situ hybridization. Leuk Lymphoma 2003; 44: 867-869.
18. Gozzetti A, Bocchia M, Crupi R, et al. Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: A different clonal origin shown by molecular cytogenetics. Cancer Genet Cytogenet 2008; 180: 83-84.
19. Mossafa H, Fourcade C, Pulic M, et al. Chronic lymphocytic leukemia associated with myelodysplastic syndrome and/or chronic myeloid leukemia: Evidence for independent clonal chromosomal evolution. Leuk Lymphoma 2001; 41: 337-341.
20. Carcassonne Y, Gascard E. Leucèmie myèloïde succédant à una leucèmie lymphoïde. Marseille Médical 1968; 105: 339-341.
21. Whang-Peng J, Gralnick HR, Johnson RE, et al. Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): Correlation of blood, marrow and spleen morphology and cytogenetics. Blood 1974; 43: 333-339.
22. Khojasteh A, Perry MC, Taylor HM. Chronic myelocytic leukemia developing as a second cancer in a patient with chronic lymphocytic leukemia. CA-A Cancer J Clin 1981; 31: 172-176.
23. Schreiber ZA, Axelrod MR, Abebe LS. Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia. Cancer 1984; 54: 697-701.
24. Hashimi L, Al-Katib A, Mertelsmann R, et al. Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia. Am J Med 1986; 80: 269-275.
25. Teichmann JV, Sieber G, Ludwig WD, et al. Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia. Leuk Res 1986; 10: 361-368.
26. Zollino M, Genuardi M, Tanci P, et al. Chronic myelogenous leukemia in the course of chronic lymphocytic leukemia: Evidence for an independent clonal origin. Leuk Res 1991; 15: 269-273.
27. Nanjangud GJ, Saikia TK, Chopra H, et al. Development of Ph positive chronic myeloid leukemia in a patient with chronic lymphocytic leukemia treated with total body irradiation: A rare association. Leuk Lymphoma 1996; 22: 355-359.
28. Faguet GB, Little T, Agee JF, et al. Chronic lymphocytic leukemia evolving into chronic myelocytic leukemia. Cancer 1983; 52: 1647-1652.
29. Ramanarayanan J, Dunford LM, Baer LM, et al. Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients. Leuk Res 2006; 30: 701-705.
30. Serpa M, Benedit I, Seguro F, et al. Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia. Acta Haematol 2010; 124: 105-109.
31. Tabaczewski P, Nadesan S, Lim SH. Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: A common defective stem cell? Leuk Res 2009; 33: 854-855.
32. Bizzaro N. Chronic lymphocytic leukaemia in a patient with essential thrombocythemia. Clin Lab Haematol 1998; 20: 377-379.
33. Henry L, Carillo S, Jourdan E, et al. Association of essential thrombocythemia and chronic lymphocytic leukemia: Absence of the V617F Jak2 mutation in the lymphoid compartment. Am J Hematol 2007; 82: 500-501.
34. Vannucchi AM, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev 2009; 18: 2068-2073.
35. Rumi E, Passamonti F, Elena C, et al. Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: A study of 1915 patients. Haematologica 2011; 96: 454-458.
36. Gabrail NY, Martin TW. Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 1991; 85: 31-33.
37. Marcos Sanchez F, Juarez Ucerlay F, Lobato de Blas C, et al. Simultaneous presentation of chronic lymphocytic leukosis and essential thrombocythemia. Ann Med Interne 1995; 12: 566.
38. Robak T, Urbanska-Rys H, Gora-Tybor J, et al. Coexistence of chronic lymphocytie leukemia and essential thrombocythemia. Leuk Lymphoma 2003; 44: 1425-1431.
39. Mir Madjlessi SH, Farmer RG, Weick JK. Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature. Dig Dis Sci 1986; 31: 1025-1031
40. Hussein K, Brakensiek K, Ballmaier M, et al. B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 2006; 77: 539-541.
41. Papayannis AG, Nikiforakis E, Aanagnostou-Keramida D. Development of chronic lymphocytic leukaemia in a patient with polycythaemia vera. Scand J Haematol 1982; 29: 65-69.
42. Jacobsen N, Theilade K, Videbaek A. Two additional cases of coexisting polycythaemia vera and chronic lymphocytic leukaemia. Scand J Haematol 1982; 29: 405-410.
43. Carulli G, Marini A, Baicchi U, et al. Chronic lymphocytic leukemia (B-cell) in the course of polycythemia vera. Description of a case with an unusual chromosomic anomaly. Tumori 1987; 73: 639-643.
44. Koza I, Babusikova O. Sequential development of chronic lymphocytic leukemia in a patient with polycythemia vera. Neoplasma 1988; 35: 77-80.
45. Vianna NJ, Essman LJ. Suppression of chronic lymphocytic leukemia by polycythemia vera. Cancer 1971; 27: 1337-1341.
46. Polkowska-Kulesza E, Matusewicz W, Golebiowska A, et al. The coexistence of chronic lymphocytic leukaemia and polycythaemia vera terminating in acute myeloid leukaemia. Folia Haematol Int Mag Klin Morphol Blutforsch 1988; 115: 647-652.
47. Botelho de Sousa A, Gouveia J. Coexistent chronic lymphocytic leukemia and polycythemia vera requiring no treatment. Med Oncol Tumor Pharmacother 1989; 6: 239-240.
48. Marisavljević D, Radosević-Radojković N, Basara B, et al. Chronic lymphocytic leukaemia associated with polycythemia vera. Srp Arh Celok Lek 1994; 122: 353-355.
49. Hernández Nieto L, Raya Sánchez JM. Diagnóstico simultaneo de leucemia linfocítica crónica y Policitemia vera en un paciente. An Med Interna 2002; 19: 102-103.
50. Januszewicz E, Firkin FC. Dual presentation of polycythaemia vera and lymphatic leukemia. Aust N Z J Med 1980; 10: 209-211
51. Wang G, Ahn YS, Whitcomb CC, et al. Development of polycythemia vera and chronic lymphocytic leukemia during the course of refractory idiopathic thrombocytopenic purpura. Cancer 1984; 53: 1770-1776.
52. Taberner DA, Chang J, Otridge BW. Co-existent chronic lymphatic leukemia with polycythaemia vera. Postgrad Med J 1977; 53: 222-223.
53. Hernández Sánchez MC, García Quiroga H, Ulibarrena Redondo C, et al. Concurrent lymphoproliferative and myeloproliferative disorders in three patients. An Med Interna 2008; 25: 78-80.
54. Nieto LH, Raya Sánchez JM, Arguelles HA, et al. A case of chronic lymphocytic leukemia overwhelmed by rapidly progressive idiopathic myelofibrosis. Haematologica 2000; 85: 973-977.
55. Hisada M, Biggar RJ, Greene MH, et al. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 98: 1979-1981.
56. Flamm MJ, Murty VV, Rao PH, et al. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea. Leuk Res 2002; 26: 417-420.
57. Zhang X, Ji L, Liu S, et al. Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia. Leuk Res 2003; 27: 367-369.
58. Annoh S, Umeda M, Arai N, et al. Chronic myelocytic leukemia induced into remission by interferon-alpha associated with early esophageal cancer. Rinsho Ketsueki 1991; 32: 786-790.
59. Swerdlow SHCE, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid tissues. Lyon: IARC; 2008.
60. Hallek M, Cheson BD, Catovsky D, et al. guidelines for the diagnosis and treatment of chronic lymphocytic leukemia updating the Natinal Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-5456.
61. Marti GE, Rawstron AC, Ghia P, et al. diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325-332.
62. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: The importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. Br J Haematol 1989; 72: 141-149.
63. Wierda WG, O'Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 2007; 109: 4679-4685.
64. Rossi D, Sozzi E, Puma A, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009; 146: 64-75.
65. Morabito F, Cutrona G, Gentile M, et al. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukemia. Br J Haematol 2009; 146: 44-53.
66. Zauli G, Voltan R, Bosco R, et al. Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53-wild type and p53 mutated B-chronic lymphocytic leukemias by inhibiting the Akt pathway. Clin Cancer Res 2011; 17: 762-770.